nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—peripheral nervous system neoplasm	0.252	1	CbGaD
Midazolam—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0497	0.0967	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0497	0.0967	CbGbCtD
Midazolam—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0473	0.0921	CbGbCtD
Midazolam—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0412	0.0803	CbGbCtD
Midazolam—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0372	0.0725	CbGbCtD
Midazolam—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0261	0.0508	CbGbCtD
Midazolam—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0261	0.0508	CbGbCtD
Midazolam—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0228	0.0444	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0228	0.0444	CbGbCtD
Midazolam—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0202	0.0394	CbGbCtD
Midazolam—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0202	0.0393	CbGbCtD
Midazolam—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0181	0.0352	CbGbCtD
Midazolam—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0171	0.0333	CbGbCtD
Midazolam—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0157	0.0305	CbGbCtD
Midazolam—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0156	0.0304	CbGbCtD
Midazolam—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0145	0.0283	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0136	0.0264	CbGbCtD
Midazolam—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0111	0.0217	CbGbCtD
Midazolam—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0104	0.0202	CbGbCtD
Midazolam—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0102	0.0199	CbGbCtD
Midazolam—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00696	0.0135	CbGbCtD
Midazolam—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00667	0.013	CbGbCtD
Midazolam—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00611	0.0119	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00417	0.00812	CbGbCtD
Midazolam—GABRR3—nerve—peripheral nervous system neoplasm	0.00209	0.109	CbGeAlD
Midazolam—GABRQ—nerve—peripheral nervous system neoplasm	0.00209	0.109	CbGeAlD
Midazolam—GABRR2—nerve—peripheral nervous system neoplasm	0.00181	0.0946	CbGeAlD
Midazolam—GABRR1—nerve—peripheral nervous system neoplasm	0.00174	0.0911	CbGeAlD
Midazolam—GABRG1—ganglion—peripheral nervous system neoplasm	0.00144	0.0753	CbGeAlD
Midazolam—CYP4B1—trigeminal ganglion—peripheral nervous system neoplasm	0.00109	0.057	CbGeAlD
Midazolam—GABRA2—ganglion—peripheral nervous system neoplasm	0.000962	0.0503	CbGeAlD
Midazolam—SLC22A1—ganglion—peripheral nervous system neoplasm	0.000908	0.0475	CbGeAlD
Midazolam—GABRA6—brainstem—peripheral nervous system neoplasm	0.000622	0.0325	CbGeAlD
Midazolam—GABRG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000517	0.0271	CbGeAlD
Midazolam—CYP4B1—cerebellum—peripheral nervous system neoplasm	0.000476	0.0249	CbGeAlD
Midazolam—GABRE—trigeminal ganglion—peripheral nervous system neoplasm	0.000468	0.0245	CbGeAlD
Midazolam—GABRB2—brainstem—peripheral nervous system neoplasm	0.000458	0.0239	CbGeAlD
Midazolam—GABRA2—brainstem—peripheral nervous system neoplasm	0.000418	0.0219	CbGeAlD
Midazolam—GABRA1—brainstem—peripheral nervous system neoplasm	0.000404	0.0211	CbGeAlD
Midazolam—GABRB3—trigeminal ganglion—peripheral nervous system neoplasm	0.000397	0.0208	CbGeAlD
Midazolam—GABRR2—cerebellum—peripheral nervous system neoplasm	0.000383	0.02	CbGeAlD
Midazolam—GABRD—cerebellum—peripheral nervous system neoplasm	0.00032	0.0168	CbGeAlD
Midazolam—GABRG1—cerebellum—peripheral nervous system neoplasm	0.000308	0.0161	CbGeAlD
Midazolam—GABRA6—cerebellum—peripheral nervous system neoplasm	0.000306	0.016	CbGeAlD
Midazolam—GABRB1—cerebellum—peripheral nervous system neoplasm	0.000299	0.0156	CbGeAlD
Midazolam—GABRA4—cerebellum—peripheral nervous system neoplasm	0.00027	0.0141	CbGeAlD
Midazolam—GABRB2—cerebellum—peripheral nervous system neoplasm	0.000226	0.0118	CbGeAlD
Midazolam—GABRG2—cerebellum—peripheral nervous system neoplasm	0.000226	0.0118	CbGeAlD
Midazolam—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000219	0.00102	CcSEcCtD
Midazolam—Chills—Etoposide—peripheral nervous system neoplasm	0.000218	0.00102	CcSEcCtD
Midazolam—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00102	CcSEcCtD
Midazolam—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00102	CcSEcCtD
Midazolam—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.00101	CcSEcCtD
Midazolam—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000217	0.00101	CcSEcCtD
Midazolam—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000217	0.00101	CcSEcCtD
Midazolam—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00101	CcSEcCtD
Midazolam—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000215	0.001	CcSEcCtD
Midazolam—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000215	0.001	CcSEcCtD
Midazolam—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.001	CcSEcCtD
Midazolam—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000213	0.000996	CcSEcCtD
Midazolam—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000212	0.000992	CcSEcCtD
Midazolam—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000988	CcSEcCtD
Midazolam—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000211	0.000986	CcSEcCtD
Midazolam—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000983	CcSEcCtD
Midazolam—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.000978	CcSEcCtD
Midazolam—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00021	0.000978	CcSEcCtD
Midazolam—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000209	0.000977	CcSEcCtD
Midazolam—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000208	0.000973	CcSEcCtD
Midazolam—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000207	0.000966	CcSEcCtD
Midazolam—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.000966	CcSEcCtD
Midazolam—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000207	0.000965	CcSEcCtD
Midazolam—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000207	0.000965	CcSEcCtD
Midazolam—GABRA2—cerebellum—peripheral nervous system neoplasm	0.000206	0.0108	CbGeAlD
Midazolam—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000206	0.000961	CcSEcCtD
Midazolam—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000204	0.000953	CcSEcCtD
Midazolam—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000204	0.000952	CcSEcCtD
Midazolam—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000951	CcSEcCtD
Midazolam—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000943	CcSEcCtD
Midazolam—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000939	CcSEcCtD
Midazolam—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000199	0.000931	CcSEcCtD
Midazolam—GABRA1—cerebellum—peripheral nervous system neoplasm	0.000199	0.0104	CbGeAlD
Midazolam—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.000928	CcSEcCtD
Midazolam—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000921	CcSEcCtD
Midazolam—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00092	CcSEcCtD
Midazolam—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00092	CcSEcCtD
Midazolam—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000919	CcSEcCtD
Midazolam—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.000919	CcSEcCtD
Midazolam—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000196	0.000915	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000912	CcSEcCtD
Midazolam—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00091	CcSEcCtD
Midazolam—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000195	0.000909	CcSEcCtD
Midazolam—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000906	CcSEcCtD
Midazolam—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000193	0.000902	CcSEcCtD
Midazolam—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000193	0.000902	CcSEcCtD
Midazolam—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000192	0.000894	CcSEcCtD
Midazolam—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.000892	CcSEcCtD
Midazolam—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.000891	CcSEcCtD
Midazolam—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00019	0.000888	CcSEcCtD
Midazolam—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000884	CcSEcCtD
Midazolam—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000884	CcSEcCtD
Midazolam—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000189	0.000881	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00088	CcSEcCtD
Midazolam—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000875	CcSEcCtD
Midazolam—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000187	0.000874	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000872	CcSEcCtD
Midazolam—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000872	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000869	CcSEcCtD
Midazolam—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.000867	CcSEcCtD
Midazolam—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000186	0.000867	CcSEcCtD
Midazolam—Rash—Topotecan—peripheral nervous system neoplasm	0.000186	0.000867	CcSEcCtD
Midazolam—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000186	0.000866	CcSEcCtD
Midazolam—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000865	CcSEcCtD
Midazolam—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000864	CcSEcCtD
Midazolam—Cough—Etoposide—peripheral nervous system neoplasm	0.000185	0.000863	CcSEcCtD
Midazolam—Headache—Topotecan—peripheral nervous system neoplasm	0.000184	0.000861	CcSEcCtD
Midazolam—Rash—Tretinoin—peripheral nervous system neoplasm	0.000184	0.00086	CcSEcCtD
Midazolam—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.00086	CcSEcCtD
Midazolam—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000184	0.00086	CcSEcCtD
Midazolam—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000184	0.000859	CcSEcCtD
Midazolam—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.000859	CcSEcCtD
Midazolam—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000184	0.000859	CcSEcCtD
Midazolam—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000184	0.000859	CcSEcCtD
Midazolam—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000183	0.000856	CcSEcCtD
Midazolam—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000183	0.000855	CcSEcCtD
Midazolam—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000183	0.000854	CcSEcCtD
Midazolam—Headache—Tretinoin—peripheral nervous system neoplasm	0.000183	0.000854	CcSEcCtD
Midazolam—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000852	CcSEcCtD
Midazolam—Pain—Vincristine—peripheral nervous system neoplasm	0.000182	0.000852	CcSEcCtD
Midazolam—Constipation—Vincristine—peripheral nervous system neoplasm	0.000182	0.000852	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000851	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000851	CcSEcCtD
Midazolam—Rash—Melphalan—peripheral nervous system neoplasm	0.000182	0.000849	CcSEcCtD
Midazolam—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000182	0.000848	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000838	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000179	0.000836	CcSEcCtD
Midazolam—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000176	0.000823	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000823	CcSEcCtD
Midazolam—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.000821	CcSEcCtD
Midazolam—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000821	CcSEcCtD
Midazolam—Nausea—Topotecan—peripheral nervous system neoplasm	0.000175	0.000817	CcSEcCtD
Midazolam—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000174	0.000813	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000812	CcSEcCtD
Midazolam—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000174	0.00081	CcSEcCtD
Midazolam—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.00081	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00081	CcSEcCtD
Midazolam—GABRB3—cerebellum—peripheral nervous system neoplasm	0.000173	0.00907	CbGeAlD
Midazolam—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000173	0.000807	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000807	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000801	CcSEcCtD
Midazolam—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.0008	CcSEcCtD
Midazolam—Nausea—Melphalan—peripheral nervous system neoplasm	0.000171	0.0008	CcSEcCtD
Midazolam—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000791	CcSEcCtD
Midazolam—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000169	0.000787	CcSEcCtD
Midazolam—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000785	CcSEcCtD
Midazolam—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000168	0.000784	CcSEcCtD
Midazolam—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000761	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000761	CcSEcCtD
Midazolam—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00076	CcSEcCtD
Midazolam—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000161	0.000754	CcSEcCtD
Midazolam—Pain—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000753	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000751	CcSEcCtD
Midazolam—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000742	CcSEcCtD
Midazolam—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000157	0.000734	CcSEcCtD
Midazolam—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.000731	CcSEcCtD
Midazolam—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000726	CcSEcCtD
Midazolam—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000155	0.000724	CcSEcCtD
Midazolam—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000154	0.000719	CcSEcCtD
Midazolam—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000154	0.000717	CcSEcCtD
Midazolam—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000153	0.000715	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000709	CcSEcCtD
Midazolam—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.000709	CcSEcCtD
Midazolam—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.000703	CcSEcCtD
Midazolam—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000149	0.000697	CcSEcCtD
Midazolam—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000149	0.000696	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000695	CcSEcCtD
Midazolam—Pain—Etoposide—peripheral nervous system neoplasm	0.000148	0.00069	CcSEcCtD
Midazolam—Constipation—Etoposide—peripheral nervous system neoplasm	0.000148	0.00069	CcSEcCtD
Midazolam—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000683	CcSEcCtD
Midazolam—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000144	0.00753	CbGeAlD
Midazolam—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000142	0.000665	CcSEcCtD
Midazolam—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000142	0.000662	CcSEcCtD
Midazolam—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000141	0.000659	CcSEcCtD
Midazolam—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000657	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000656	CcSEcCtD
Midazolam—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000652	CcSEcCtD
Midazolam—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000651	CcSEcCtD
Midazolam—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000649	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000648	CcSEcCtD
Midazolam—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000647	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000643	CcSEcCtD
Midazolam—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000137	0.000641	CcSEcCtD
Midazolam—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000136	0.000633	CcSEcCtD
Midazolam—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000135	0.000632	CcSEcCtD
Midazolam—Rash—Vincristine—peripheral nervous system neoplasm	0.000135	0.000628	CcSEcCtD
Midazolam—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000134	0.000627	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000626	CcSEcCtD
Midazolam—Headache—Vincristine—peripheral nervous system neoplasm	0.000134	0.000624	CcSEcCtD
Midazolam—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000614	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000613	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.0006	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000595	CcSEcCtD
Midazolam—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000127	0.000594	CcSEcCtD
Midazolam—Nausea—Vincristine—peripheral nervous system neoplasm	0.000127	0.000592	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000591	CcSEcCtD
Midazolam—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000124	0.000579	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000579	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000575	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000574	CcSEcCtD
Midazolam—Chills—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000571	CcSEcCtD
Midazolam—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000122	0.000571	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000568	CcSEcCtD
Midazolam—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00012	0.00056	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000558	CcSEcCtD
Midazolam—Rash—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000555	CcSEcCtD
Midazolam—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000555	CcSEcCtD
Midazolam—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000554	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00055	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000547	CcSEcCtD
Midazolam—Tension—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000544	CcSEcCtD
Midazolam—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000538	CcSEcCtD
Midazolam—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000114	0.000533	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000532	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000531	CcSEcCtD
Midazolam—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000528	CcSEcCtD
Midazolam—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000523	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000522	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000516	CcSEcCtD
Midazolam—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.00011	0.00577	CbGeAlD
Midazolam—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00011	0.000513	CcSEcCtD
Midazolam—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000513	CcSEcCtD
Midazolam—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000509	CcSEcCtD
Midazolam—Rash—Etoposide—peripheral nervous system neoplasm	0.000109	0.000509	CcSEcCtD
Midazolam—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000109	0.000508	CcSEcCtD
Midazolam—Headache—Etoposide—peripheral nervous system neoplasm	0.000108	0.000505	CcSEcCtD
Midazolam—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000503	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000498	CcSEcCtD
Midazolam—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000498	CcSEcCtD
Midazolam—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000497	CcSEcCtD
Midazolam—Cough—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000484	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000483	CcSEcCtD
Midazolam—Nausea—Etoposide—peripheral nervous system neoplasm	0.000103	0.000479	CcSEcCtD
Midazolam—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000471	CcSEcCtD
Midazolam—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00047	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000468	CcSEcCtD
Midazolam—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000461	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000461	CcSEcCtD
Midazolam—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.00046	CcSEcCtD
Midazolam—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000456	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000452	CcSEcCtD
Midazolam—Cough—Doxorubicin—peripheral nervous system neoplasm	9.58e-05	0.000447	CcSEcCtD
Midazolam—Shock—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000445	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000443	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000441	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000439	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000435	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000433	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000427	CcSEcCtD
Midazolam—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000423	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000422	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000418	CcSEcCtD
Midazolam—Shock—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.000412	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.00041	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.000408	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000406	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000406	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000403	CcSEcCtD
Midazolam—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000402	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000398	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000391	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.00039	CcSEcCtD
Midazolam—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.00039	CcSEcCtD
Midazolam—Pain—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000387	CcSEcCtD
Midazolam—Constipation—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000387	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000376	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000373	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000373	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000372	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000368	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000361	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000361	CcSEcCtD
Midazolam—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000359	CcSEcCtD
Midazolam—Pain—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000358	CcSEcCtD
Midazolam—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000358	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000345	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000333	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000332	CcSEcCtD
Midazolam—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000324	CcSEcCtD
Midazolam—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.00032	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000308	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.0003	CcSEcCtD
Midazolam—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000299	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000296	CcSEcCtD
Midazolam—ABCB1—cerebellum—peripheral nervous system neoplasm	6.28e-05	0.00329	CbGeAlD
Midazolam—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000288	CcSEcCtD
Midazolam—Rash—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000285	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000285	CcSEcCtD
Midazolam—Headache—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.000283	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000277	CcSEcCtD
Midazolam—Nausea—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000269	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000266	CcSEcCtD
Midazolam—Rash—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000264	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000264	CcSEcCtD
Midazolam—Headache—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000262	CcSEcCtD
Midazolam—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000249	CcSEcCtD
Midazolam—Ketazolam—ABCB1—peripheral nervous system neoplasm	1.87e-05	0.313	CrCbGaD
Midazolam—Clobazam—ABCB1—peripheral nervous system neoplasm	1.32e-05	0.221	CrCbGaD
Midazolam—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	1.04e-05	0.174	CrCbGaD
Midazolam—Flurazepam—ABCB1—peripheral nervous system neoplasm	9.7e-06	0.163	CrCbGaD
Midazolam—Diazepam—ABCB1—peripheral nervous system neoplasm	7.71e-06	0.129	CrCbGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	6.84e-06	0.00425	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	6.72e-06	0.00418	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	6.68e-06	0.00415	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	6.66e-06	0.00414	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	6.65e-06	0.00414	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	6.58e-06	0.00409	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GNS—peripheral nervous system neoplasm	6.58e-06	0.00409	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	6.56e-06	0.00408	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—BCHE—peripheral nervous system neoplasm	6.53e-06	0.00406	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—BCHE—peripheral nervous system neoplasm	6.43e-06	0.004	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.33e-06	0.00393	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—NME1—peripheral nervous system neoplasm	6.3e-06	0.00392	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.23e-06	0.00388	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—BCHE—peripheral nervous system neoplasm	6.08e-06	0.00378	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—COX2—peripheral nervous system neoplasm	6.07e-06	0.00377	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—BCHE—peripheral nervous system neoplasm	6.01e-06	0.00374	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.9e-06	0.00367	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.82e-06	0.00362	CbGpPWpGaD
Midazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.78e-06	0.00359	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	5.73e-06	0.00357	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.69e-06	0.00354	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.59e-06	0.00347	CbGpPWpGaD
Midazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.51e-06	0.00342	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—BCHE—peripheral nervous system neoplasm	5.49e-06	0.00342	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	5.36e-06	0.00333	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—BCHE—peripheral nervous system neoplasm	5.34e-06	0.00332	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.33e-06	0.00331	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—BCHE—peripheral nervous system neoplasm	5.24e-06	0.00326	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.17e-06	0.00322	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—BCHE—peripheral nervous system neoplasm	5.15e-06	0.0032	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—BCHE—peripheral nervous system neoplasm	5.12e-06	0.00318	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.08e-06	0.00316	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—BCHE—peripheral nervous system neoplasm	5.03e-06	0.00313	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.99e-06	0.00311	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.96e-06	0.00308	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	4.91e-06	0.00305	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.87e-06	0.00303	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	4.63e-06	0.00288	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—BCHE—peripheral nervous system neoplasm	4.39e-06	0.00273	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.26e-06	0.00265	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.26e-06	0.00265	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GNS—peripheral nervous system neoplasm	4.11e-06	0.00256	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.07e-06	0.00253	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.07e-06	0.00253	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.07e-06	0.00253	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.98e-06	0.00248	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NME1—peripheral nervous system neoplasm	3.94e-06	0.00245	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—COX2—peripheral nervous system neoplasm	3.8e-06	0.00236	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.79e-06	0.00236	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.79e-06	0.00235	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	3.76e-06	0.00234	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.64e-06	0.00227	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.43e-06	0.00213	CbGpPWpGaD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	3.38e-06	0.00211	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.37e-06	0.00209	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.36e-06	0.00209	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.35e-06	0.00208	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	3.32e-06	0.00207	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.3e-06	0.00205	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.27e-06	0.00203	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.27e-06	0.00203	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	3.23e-06	0.00201	CbGpPWpGaD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	3.23e-06	0.00201	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.21e-06	0.002	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.21e-06	0.002	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.21e-06	0.002	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—TH—peripheral nervous system neoplasm	3.16e-06	0.00197	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.12e-06	0.00194	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.08e-06	0.00192	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.01e-06	0.00187	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.95e-06	0.00183	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.94e-06	0.00183	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.82e-06	0.00175	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.75e-06	0.00171	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.74e-06	0.0017	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.74e-06	0.0017	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.69e-06	0.00168	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.69e-06	0.00167	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.68e-06	0.00166	CbGpPWpGaD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.66e-06	0.00165	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.65e-06	0.00165	CbGpPWpGaD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.65e-06	0.00165	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.64e-06	0.00164	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.64e-06	0.00164	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.62e-06	0.00163	CbGpPWpGaD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.62e-06	0.00163	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.6e-06	0.00162	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.58e-06	0.00161	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.58e-06	0.0016	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.56e-06	0.00159	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.54e-06	0.00158	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.54e-06	0.00158	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.51e-06	0.00156	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.5e-06	0.00155	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.49e-06	0.00155	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.48e-06	0.00154	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.48e-06	0.00154	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.46e-06	0.00153	CbGpPWpGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.45e-06	0.00152	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.43e-06	0.00151	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.43e-06	0.00151	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.43e-06	0.00151	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.31e-06	0.00144	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.28e-06	0.00142	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.27e-06	0.00141	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.25e-06	0.0014	CbGpPWpGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.24e-06	0.00139	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.23e-06	0.00138	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.22e-06	0.00138	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.2e-06	0.00137	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.17e-06	0.00135	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.16e-06	0.00135	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.16e-06	0.00134	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.14e-06	0.00133	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.14e-06	0.00133	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.13e-06	0.00132	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.12e-06	0.00132	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.11e-06	0.00131	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.11e-06	0.00131	CbGpPWpGaD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.1e-06	0.0013	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.09e-06	0.0013	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.08e-06	0.0013	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.07e-06	0.00129	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.07e-06	0.00129	CbGpPWpGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.05e-06	0.00127	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	2.04e-06	0.00127	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.04e-06	0.00127	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.03e-06	0.00126	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.01e-06	0.00125	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2e-06	0.00124	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.99e-06	0.00124	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	1.99e-06	0.00124	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.99e-06	0.00124	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TH—peripheral nervous system neoplasm	1.98e-06	0.00123	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.97e-06	0.00122	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.95e-06	0.00121	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.93e-06	0.0012	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.9e-06	0.00118	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.86e-06	0.00116	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.86e-06	0.00116	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—HRAS—peripheral nervous system neoplasm	1.86e-06	0.00116	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	1.85e-06	0.00115	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.84e-06	0.00114	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.83e-06	0.00114	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.81e-06	0.00113	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	1.8e-06	0.00112	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	1.79e-06	0.00111	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.78e-06	0.00111	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	1.77e-06	0.0011	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	1.71e-06	0.00106	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.68e-06	0.00105	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.63e-06	0.00102	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.62e-06	0.00101	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.61e-06	0.000998	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.59e-06	0.000986	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.58e-06	0.000981	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.57e-06	0.000975	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.55e-06	0.000965	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.54e-06	0.000957	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—HRAS—peripheral nervous system neoplasm	1.53e-06	0.000953	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.52e-06	0.000947	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.51e-06	0.000938	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.5e-06	0.000932	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.47e-06	0.000914	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.45e-06	0.000899	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	1.44e-06	0.000895	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.44e-06	0.000893	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—HRAS—peripheral nervous system neoplasm	1.43e-06	0.000888	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—HRAS—peripheral nervous system neoplasm	1.41e-06	0.000877	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.41e-06	0.000876	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	1.38e-06	0.000858	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.38e-06	0.000856	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.37e-06	0.00085	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.36e-06	0.000843	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.35e-06	0.000837	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.33e-06	0.000826	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.33e-06	0.000824	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.29e-06	0.000802	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.26e-06	0.000782	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—HRAS—peripheral nervous system neoplasm	1.25e-06	0.000779	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—HRAS—peripheral nervous system neoplasm	1.23e-06	0.000765	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.21e-06	0.000752	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-06	0.000749	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—HRAS—peripheral nervous system neoplasm	1.2e-06	0.000747	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.18e-06	0.000733	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.15e-06	0.000716	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.14e-06	0.00071	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.13e-06	0.000703	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.12e-06	0.000697	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.08e-06	0.000674	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-06	0.000646	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.03e-06	0.000641	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-06	0.000633	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1e-06	0.000622	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.7e-07	0.000603	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	9.56e-07	0.000595	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.47e-07	0.000589	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.24e-07	0.000574	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.09e-07	0.000565	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.03e-07	0.000562	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.91e-07	0.000554	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	8.9e-07	0.000554	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	8.9e-07	0.000553	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	8.82e-07	0.000548	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	8.72e-07	0.000542	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	8.7e-07	0.000541	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	7.81e-07	0.000486	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	7.66e-07	0.000476	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	7.52e-07	0.000468	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	7.37e-07	0.000458	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.35e-07	0.000457	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.32e-07	0.000455	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	7.27e-07	0.000452	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.18e-07	0.000446	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.13e-07	0.000443	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	7.07e-07	0.00044	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.03e-07	0.000437	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.01e-07	0.000436	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—peripheral nervous system neoplasm	6.97e-07	0.000434	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	6.93e-07	0.000431	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	6.91e-07	0.00043	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.68e-07	0.000415	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.57e-07	0.000408	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.4e-07	0.000398	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.18e-07	0.000384	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.16e-07	0.000383	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	5.77e-07	0.000359	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.67e-07	0.000352	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	5.65e-07	0.000352	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.64e-07	0.000351	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.55e-07	0.000345	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.55e-07	0.000345	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.54e-07	0.000344	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.29e-07	0.000329	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.22e-07	0.000324	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.36e-07	0.000271	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.26e-07	0.000265	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.05e-07	0.000252	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.42e-07	0.000213	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.26e-07	0.000203	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.21e-07	0.0002	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.62e-07	0.000163	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.57e-07	0.00016	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.11e-07	0.000131	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.96e-07	0.000122	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-07	9.69e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.53e-07	9.49e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.52e-07	9.47e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-07	7.15e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.08e-08	4.4e-05	CbGpPWpGaD
